-
Narcan is a nasal-spray version of the life-saving medication naloxone, which can reverse an opioid overdose. It recently became available over-the-counter. Here’s what that means for public access.
-
As money is funneled to states, opioid councils wield significant power in determining how it gets spent. They face concerns about conflicts of interest and lack of representation by affected groups.
-
In sweeping indictments, the Justice Department targeted two dozen operatives in the Chapitos network of the Sinaloa cartel. But many drug policy experts say this won't slow fentanyl deaths.
-
Methamphetamine is killing more Oklahomans than any illicit drug. Nonprofits, treatment centers, policy analysts and law enforcement in Tulsa created a program to broaden access to recovery from it.
-
Billion-dollar lawsuits and prestige television shows have made the opioid epidemic impossible to overlook. But it is far from the only drug epidemic the country — and Oklahoma — are facing.
-
The cash represents an unprecedented opportunity to derail the opioid epidemic. But with countless groups advocating for a share of the pie, the impact could depend heavily on geography and politics.
-
It could amount to the last round of huge settlements after years of litigation over the industry's role in an overdose crisis linked to more than 500,000 deaths in the U.S. over the past two decades.
-
Two Washington Post journalists say pharmaceutical companies collaborated with each other — and with lawyers and lobbyists — to create laws to protect the industry. Their new book is American Cartel.
-
The Biden administration says it has a plan to curb fatal overdoses by 13% by 2025. But as more synthetic opioids reach the U.S., there's skepticism interdiction can slow the flow of deadly drugs.
-
Overdose deaths have risen sharply across Canada in the past five years, with deaths linked to fentanyl doubling. Officials hope decriminalization will make more users willing to seek medical care.